Previous Article | Next Article ![]()
Mol. Cell. Biol., Mar 1995, 1294-1301, Vol 15, No. 3
I Alkalay, A Yaron, A Hatzubai, S Jung, A Avraham, O Gerlitz, I Pashut-Lavon and Y Ben-Neriah
NF-kappa B is a major inducible transcription factor in many immune and
inflammatory reactions. Its activation involves the dissociation of the
inhibitory subunit I kappa B from cytoplasmic NF-kappa B/Rel complexes,
following which the Rel proteins are translocated to the nucleus, where
they bind to DNA and activate transcription. Phosphorylation of I kappa B
in cell-free experiments results in its inactivation and release from the
Rel complex, but in vivo NF-kappa B activation is associated with I kappa B
degradation. In vivo phosphorylation of I kappa B alpha was demonstrated in
several recent studies, but its role is unknown. Our study shows that the
T-cell activation results in rapid phosphorylation of I kappa B alpha and
that this event is a physiological one, dependent on appropriate lymphocyte
costimulation. Inducible I kappa B alpha phosphorylation was abolished by
several distinct NF-kappa B blocking reagents, suggesting that it plays an
essential role in the activation process. However, the in vivo induction of
I kappa B alpha phosphorylation did not cause the inhibitory subunit to
dissociate from the Rel complex. We identified several protease inhibitors
which allow phosphorylation of I kappa B alpha but prevent its degradation
upon cell stimulation, presumably through inhibition of the cytoplasmic
proteasome. In the presence of these inhibitors, phosphorylated I kappa B
alpha remained bound to the Rel complex in the cytoplasm for an extended
period of time, whereas NF-kappa B activation was abolished.(ABSTRACT
TRUNCATED AT 250 WORDS)
Copyright © 1995, American Society for Microbiology
In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B
Lautenberg Center for General and Tumor Immunology, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|